goserelin has been researched along with Acute-Disease* in 3 studies
1 review(s) available for goserelin and Acute-Disease
| Article | Year |
|---|---|
[The use of GnRH agonists in severe uterine hemorrhages in adolescence caused by congenital aplastic and hypoplastic anemias].
GnRH agonists, applied for a long period of time or as depot forms, lead to blocking of gonadotropin and ovarian steroid synthesis. We used their property to induce amenorrhea for treating menorrhagic and menometrorrhagic bleeding in adolescence caused by inborn aplastic and hypoplastic anaemia. In patients with uterine bleeding during the first regular menstrual period or recurring during menstrual periods Zoladex (depot GnRH agonist) has been applied, resulting in stop of bleeding in 2 to 4 days. The drug-induced amenorrhea provides the possibility for physiologic restoring of hemoglobin levels, improvement of therapeutic results from adjuvant antianaemic therapy. Thus a more favourable basis for treating of the main disorder is being created. When surgery is indicated, GnRH agonists provide the opportunity for planning of operating management or for laser ablation of endometrium. Topics: Acute Disease; Adolescent; Anemia, Aplastic; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Uterine Hemorrhage | 1999 |
1 trial(s) available for goserelin and Acute-Disease
| Article | Year |
|---|---|
[Treatment of acute urine retention caused by benign prostatic hypertrophy with an LH-RH agonist (Goserelin)].
Nineteen patients seen for AUR secondary to benign prostate hypertrophy and with high surgical risk, were treated with an LH-RH agonist (GOSERELIN). After six months of treatment a 43.28% decrease in the prostate volume was seen, Improvement, i.e., spontaneous miction, was achieved in 46.6% patients, although post-mictional volumes remained high. Topics: Acute Disease; Aged; Aged, 80 and over; Goserelin; Humans; Male; Prostatic Hyperplasia; Urinary Retention | 1995 |
1 other study(ies) available for goserelin and Acute-Disease
| Article | Year |
|---|---|
LHRH analogues as primary treatment for urinary retention in patients with prostatic carcinoma.
Thirty-one patients with retention of urine and carcinoma of the prostate were treated with LHRH analogues as primary therapy rather than prostatectomy; 21 patients voided without the need for surgical intervention. Patients presenting in acute retention of urine voided more readily than those presenting in chronic retention, with only 20% requiring surgery. This approach to treatment is safe, efficacious and cost effective. Topics: Acute Disease; Aged; Chronic Disease; Goserelin; Humans; Male; Prostate; Prostatic Neoplasms; Urinary Retention; Urination | 1993 |